Vectorious is developing the world's first miniature implant for left-atrial monitoring.​
RAD Biomed - the investment arm of the RAD Bynet group, focuses on investing in early-stage ventures based in Israel.
Building on our success in MedTech and HiTech, we are expanding our focus to include the Health, Technology, and Energy sectors, where we continue to operate, build, and invest.
​
We seek out companies with disruptive new solutions to real-world challenges and unmet needs
Come join our strong community of entrepreneurs, benefit from our in-house, multidisciplinary capabilities and enjoy long-term support
The RAD Bynet Group
The RAD Bynet Group is one of Israel’s most successful tech ecosystems.
We stand on a legacy that includes 17 enduring companies, 9 IPOs,
and 10 M&As.
Recognized by Business 2.0 as “The most fertile ground for Israeli entrepreneurs,” the group has shaped Israel’s innovation landscape for over four decades, launching ventures across IT, Cybersecurity, Health, and Infrastructure.
​
The RAD Group has decades of experience in guiding and nurturing startups as they grow towards commercial launch, sales growth and successful exit, (9 Nasdaq IPOs and 10 M&As).
RAD BioMed was established by Yehuda, Zohar and Prof. Nava Zisapel, to bring the
RAD Bynet Group’s entrepreneurial spirit and company-building expertise into the
healthcare space — with a mission to strengthen Israel’s MedTech industry
through hands-on early-stage investment.